Welcome Message

Dear Esteemed Participants,

Join us at the 24th Global Forum on Obesity and Metabolic Disorders, a globally recognized platform where scientific research, clinical expertise, and innovation come together to shape the future of obesity prevention, metabolic health, and patient care.

Taking place in the historic city of Rome, Italy, on May 26–27, 2027, this conference will bring together leading physicians, endocrinologists, nutritionists, obesity specialists, researchers, academicians, healthcare professionals, and industry experts from across the globe. This year’s edition focuses on advancing innovative approaches to obesity management, improving metabolic health outcomes, and exploring emerging technologies and therapeutic strategies.

From obesity prevention and nutritional interventions to metabolic syndrome, diabetes, bariatric medicine, pharmacological therapies, and personalized healthcare, the conference is designed to provide insights that are both innovative and directly applicable to real-world clinical and research environments.

Thanks & Regards

Organizing Committee

Participation/Presentation Options

The 24th Global Forum on Obesity and Metabolic Disorders offers diverse opportunities for participants to engage, present, and contribute based on their professional interests and expertise:

• Oral Presentation: Present your clinical research, case studies, scientific findings, or innovative approaches to obesity and metabolic disorders to an international audience, followed by interactive discussions and expert feedback.
• Poster Presentation: Showcase your research findings in a visual format, enabling focused one-on-one discussions and knowledge exchange with attendees and professionals.
• Keynote Presentation: Deliver a high-impact session as an invited speaker, sharing advanced insights, leadership perspectives, and emerging trends in obesity and metabolic health.
• Workshop/Symposium: Conduct or participate in specialized sessions focusing on practical strategies, clinical approaches, research methodologies, and emerging areas in obesity and metabolic medicine.
• Virtual Presentation: Present your work remotely and engage with a global audience through an interactive online platform.
• Delegate Participation: Attend the conference to gain knowledge, network with experts, and explore the latest developments in obesity, nutrition, endocrinology, and metabolic health without presenting.
• Exhibitor/Sponsor Opportunities: Organizations, pharmaceutical companies, healthcare companies, nutrition brands, technology providers, and medical device companies can showcase their products, services, and innovations while connecting with key decision-makers and stakeholders.

Each participation option is thoughtfully designed to enhance learning, professional visibility, research collaboration, and knowledge exchange in the field of obesity and metabolic disorders.

About the Conference

The 24th Global Forum on Obesity and Metabolic Disorders, scheduled for May 26–27, 2027, in Rome, Italy, is a premier global platform dedicated to advancing research, clinical practice, prevention, and innovative treatment approaches in obesity and metabolic health. The conference will bring together obesity specialists, endocrinologists, physicians, nutritionists, researchers, academicians, healthcare professionals, and industry experts to exchange knowledge, share best practices, and explore innovative approaches that improve metabolic health outcomes.

Theme: Advancing Obesity & Metabolic Health: Innovation, Prevention, and Personalized Care

Covering key areas such as obesity management, metabolic syndrome, diabetes, nutrition, bariatric medicine, endocrinology, cardiovascular-metabolic health, and emerging therapeutics, the event emphasizes the integration of scientific research with real-world clinical applications.

It will also highlight advancements in obesity pharmacotherapy, nutritional science, digital health, artificial intelligence, precision medicine, behavioral interventions, and preventive healthcare. The conference aims to foster meaningful collaboration, address the growing global burden of obesity and metabolic diseases, and empower healthcare professionals with practical insights and modern tools.

Why to Attend?

Attending the 24th Global Forum on Obesity and Metabolic Disorders offers a valuable opportunity to enhance your professional knowledge, expand your network, and stay updated with the latest advancements in obesity and metabolic healthcare.

• Gain in-depth insights into modern obesity management strategies, metabolic health, nutrition, and evidence-based approaches.
• Connect with leading obesity specialists, endocrinologists, physicians, nutritionists, researchers, and healthcare professionals from around the world.
• Enhance your practical knowledge through interactive sessions, workshops, case discussions, and expert presentations.
• Showcase your research and clinical expertise to an international audience and gain professional recognition.
• Explore advancements in obesity pharmacotherapy, bariatric interventions, digital health, artificial intelligence, and personalized medicine.
• Participate in discussions addressing the global obesity epidemic and strategies for improving metabolic health outcomes.
• Build strong professional networks that can lead to research collaborations, career growth, and new opportunities.
• Stay informed about emerging trends, innovative therapies, and future directions in obesity and metabolic medicine.

What Attendees Will Gain

Advanced Clinical & Scientific Knowledge

Gain comprehensive insights into modern approaches to obesity prevention and management, metabolic disorders, nutritional interventions, pharmacological therapies, and patient-centered treatment strategies.

Global Networking Opportunities

Connect with leading obesity specialists, endocrinologists, physicians, nutritionists, researchers, academicians, and healthcare professionals from around the world, fostering meaningful professional relationships and collaborations.

Research & Career Advancement

Explore opportunities to present research, engage in academic discussions, and build collaborations that support professional growth and career development in obesity medicine, metabolic health, nutrition, and related disciplines.

Practical Clinical Insights

Acquire real-world knowledge and evidence-based strategies that can be directly applied to obesity management, metabolic disease prevention, nutritional counseling, and multidisciplinary patient care.

Latest Trends & Innovations

Stay updated with emerging developments such as GLP-1-based therapies, obesity pharmacotherapy, precision nutrition, digital health, artificial intelligence, metabolic surgery, and personalized approaches to obesity care.

Sessions & Tracks

Track 1: Obesity Prevention and Management

This track focuses on comprehensive strategies for preventing and managing obesity across different populations. It explores lifestyle interventions, behavioural approaches, nutritional management, physical activity, and multidisciplinary obesity care. The session highlights early identification of obesity-related risks and personalized treatment planning. It also addresses long-term weight management and prevention of weight regain. The importance of patient education and sustainable lifestyle modification is emphasized. The goal is to improve obesity outcomes through evidence-based and patient-centred approaches.

Track 2: Metabolic Syndrome and Cardiometabolic Health

This track addresses the complex relationship between obesity, insulin resistance, hypertension, dyslipidaemia, and cardiovascular disease. It focuses on identifying metabolic risk factors and implementing comprehensive management strategies. The session explores preventive approaches and evidence-based interventions for reducing cardio metabolic complications. It highlights the importance of early screening and risk assessment. Participants will gain insights into integrated approaches to metabolic health. The goal is to reduce disease burden and improve long-term cardiovascular and metabolic outcomes.

Track 3: Diabetes, Obesity and Insulin Resistance

This track explores the close association between obesity, insulin resistance, prediabetes, and type 2 diabetes. It focuses on prevention, early diagnosis, lifestyle modification, and modern therapeutic approaches. The session highlights the role of weight management in improving glycemic control. It also discusses emerging medications and multidisciplinary approaches to diabetes care. Participants will explore strategies for reducing diabetes-related complications. The aim is to improve metabolic outcomes through integrated obesity and diabetes management.

Track 4: Nutrition, Diet and Weight Management

This track emphasizes the role of nutrition in obesity prevention and metabolic health. It explores dietary patterns, nutritional counselling, calorie management, healthy eating behaviors, and sustainable weight-loss strategies. The session highlights evidence-based dietary interventions and individualized nutrition planning. It also addresses nutritional challenges associated with obesity and metabolic disorders. Participants will gain practical insights into effective dietary approaches. The goal is to promote sustainable nutrition practices and healthier lifestyles.

Track 5: Obesity Pharmacotherapy and Emerging Treatments

This track focuses on the latest pharmacological approaches for obesity treatment. It explores emerging anti-obesity medications, incretin-based therapies, combination treatments, and long-term pharmacological management. The session examines treatment effectiveness, safety, patient selection, and clinical considerations. It also discusses the role of medication alongside lifestyle interventions. Participants will gain insights into evolving therapeutic strategies. The goal is to advance safe and effective medical management of obesity.

Track 6: Bariatric and Metabolic Surgery

This track addresses surgical approaches for severe obesity and related metabolic disorders. It explores bariatric procedures, patient selection, surgical outcomes, and long-term follow-up. The session highlights metabolic benefits associated with bariatric surgery, including improvements in diabetes and cardiovascular risk factors. It also discusses postoperative nutrition and patient monitoring. Multidisciplinary approaches to surgical care are emphasized. The goal is to improve outcomes and quality of life for patients undergoing metabolic surgery.

Track 7: Pediatric and Adolescent Obesity

This track focuses on the increasing burden of obesity among children and adolescents. It explores childhood nutrition, physical activity, behavioural factors, family-based interventions, and early prevention strategies. The session highlights the importance of identifying obesity-related complications at an early stage. It also addresses psychological and social factors affecting young people with obesity. Participants will learn approaches for family-centred and age-appropriate care. The aim is to promote healthy growth and prevent long-term metabolic complications.

Track 8: Women's Obesity and Metabolic Health

This track explores obesity and metabolic disorders across different stages of women's health. It addresses obesity during pregnancy, reproductive health, polycystic ovary syndrome, menopause, and associated metabolic risks. The session highlights individualized nutritional and lifestyle interventions. It also discusses hormonal and metabolic factors contributing to weight gain. Participants will gain insights into gender-specific approaches to obesity care. The goal is to improve metabolic health outcomes among women.

Track 9: Obesity, Endocrinology and Hormonal Disorders

This track examines endocrine and hormonal factors associated with obesity and abnormal weight regulation. It explores thyroid disorders, Cushing syndrome, polycystic ovary syndrome, hormonal changes, and other endocrine conditions. The session emphasizes accurate diagnosis and identification of secondary causes of obesity. It also discusses personalized management strategies. Participants will gain insights into the complex interactions between hormones and metabolism. The goal is to improve diagnosis and treatment of endocrine-related obesity.

Track 10: Behavioural, Psychological and Mental Health Aspects of Obesity

This track focuses on psychological and behavioural factors influencing obesity and weight management. It explores emotional eating, stress, body image, eating behaviours, motivation, and behavioural interventions. The session highlights the importance of mental health support within multidisciplinary obesity care. It also addresses stigma and psychological barriers to treatment. Participants will learn strategies for supporting long-term behavioural change. The goal is to promote holistic approaches to obesity management.

Track 11: Obesity, Cancer and Chronic Disease

This track explores associations between obesity and major chronic diseases, including several types of cancer. It focuses on biological mechanisms linking excess adiposity with disease development and progression. The session discusses prevention strategies, lifestyle modification, and risk reduction. It also highlights the importance of weight management in chronic disease prevention. Participants will gain insights into the broader health consequences of obesity. The aim is to strengthen integrated approaches to chronic disease prevention.

Track 12: Pediatric Metabolic Disorders and Childhood Diabetes

This track focuses on metabolic disorders affecting children and adolescents. It covers childhood diabetes, insulin resistance, dyslipidaemia, obesity-related metabolic complications, and nutritional disorders. The session explores early diagnosis, prevention, and family-centred treatment approaches. It highlights the importance of lifestyle modification and long-term monitoring. Participants will gain knowledge of emerging pediatric metabolic health strategies. The goal is to improve health outcomes among younger populations.

Track 13: Precision Medicine and Personalized Obesity Care

This track emphasizes individualized approaches to obesity prevention and treatment. It explores genetic, metabolic, behavioural, environmental, and lifestyle factors influencing weight regulation and treatment response. The session highlights precision nutrition and personalized therapeutic strategies. It also examines the potential of biomarkers and advanced data analysis. Participants will learn how personalized approaches can improve treatment effectiveness. The goal is to advance patient-specific obesity management.

Track 14: Metabolic Health, Lifestyle and Preventive Medicine

This track focuses on lifestyle-based strategies for preventing obesity and metabolic disorders. It covers physical activity, sleep, nutrition, stress management, and healthy behavioural practices. The session highlights the importance of early intervention and population-level prevention. It explores sustainable lifestyle programs and community-based health initiatives. Participants will gain practical approaches to promoting healthier lifestyles. The goal is to reduce the long-term burden of metabolic disease through prevention.

Track 15: Obesity, Gut Micro biome and Metabolic Health

This track explores the emerging relationship between the gut micro biome, obesity, nutrition, and metabolic health. It examines microbial diversity, dietary influences, inflammation, and metabolic regulation. The session highlights emerging research into microbiome-based interventions and personalized nutrition. It also discusses current challenges and future research directions. Participants will gain insights into this rapidly developing area of metabolic research. The goal is to explore innovative approaches to understanding and managing obesity.

Track 16: Digital Health, Artificial Intelligence and Obesity Care

This track explores the role of digital technologies in modern obesity and metabolic healthcare. It covers digital therapeutics, mobile health applications, wearable devices, remote monitoring, and artificial intelligence. The session highlights technology-enabled weight management and personalized patient support. It also discusses data privacy, digital accessibility, and ethical considerations. Participants will gain insights into technology-driven obesity management. The aim is to support more accessible, efficient, and personalized metabolic healthcare.

Track 17: Obesity, Aging and Metabolic Disorders

This track focuses on obesity and metabolic health among aging populations. It explores age-related changes in body composition, sarcopenic obesity, diabetes, cardiovascular risk, and functional decline. The session highlights nutritional strategies, physical activity, and individualized weight-management approaches for older adults. It also addresses the balance between weight reduction and preservation of muscle mass. Participants will gain insights into healthy aging and metabolic disease prevention. The goal is to improve quality of life and functional health among older populations.

Track 18: Global Obesity Challenges and Future Directions

This track addresses the growing global burden of obesity and metabolic disorders. It explores international trends, healthcare disparities, socioeconomic factors, public health policies, and population-based interventions. The session highlights global collaboration and innovative prevention strategies. It also discusses emerging therapies, healthcare technologies, and future directions in obesity medicine. Participants will gain insights into international approaches to addressing obesity. The goal is to strengthen global efforts toward healthier populations and improved metabolic health.

Abstract Review Process

Our abstract review process is designed to ensure high academic quality, transparency, and a fair evaluation for all submissions:

• Submission: Authors are required to submit their abstracts through the official online submission portal within the specified deadline.
• Pre-Screening: The editorial team conducts an initial review to ensure the abstract aligns with the conference theme, meets submission guidelines, and maintains clarity and structure.
• Double-Blind Evaluation: Each abstract is reviewed by independent experts in obesity, metabolic medicine, endocrinology, nutrition, and related healthcare fields without revealing the identity of the authors, ensuring an unbiased and objective assessment.

Scoring Criteria:

• Relevance to obesity and metabolic health
• Scientific and clinical merit
• Originality and innovation
• Methodological clarity and accuracy
• Alignment with the conference theme and tracks
• Decision & Notification: Based on reviewer evaluations, abstracts are accepted for Oral, Poster, or Virtual presentations. Authors will receive official notification along with reviewer comments where applicable.
• Revision Process: Authors may be requested to revise their abstracts according to expert feedback to meet the required quality standards.
• Early Submission Advantage: Early submissions receive priority in scheduling, offering better presentation slots and increased visibility during the conference.

 Required Documents:

• Valid passport (with sufficient validity)
• Completed visa application form
• Passport-size photographs
• Proof of conference registration
• Official invitation letter
• Travel itinerary (flight bookings)
• Accommodation details
• Proof of financial support
• Visa Processing Time: Processing times may vary, so applicants are advised to apply at least 4–8 weeks before the conference dates.
• Important Note: Visa approval is solely at the discretion of the embassy or consulate. Participants should ensure all documents are accurate and complete to avoid delays or rejection.

Proper planning and timely application will help ensure a smooth travel experience to attend the conference in Rome, Italy.

Market Analysis

The global obesity and metabolic disorders sector is experiencing strong and sustained growth, driven by increasing rates of obesity, sedentary lifestyles, changing dietary patterns, aging populations, and the growing burden of obesity-related chronic diseases.

The expanding demand for effective obesity-management solutions is being supported by advances in anti-obesity pharmacotherapy, metabolic surgery, nutritional interventions, digital health, and personalized medicine. Emerging therapies targeting metabolic pathways are also transforming the treatment landscape and creating new opportunities for healthcare providers, pharmaceutical companies, researchers, and technology developers.

The increasing prevalence of obesity, diabetes, cardiovascular disease, metabolic syndrome, and other obesity-associated conditions continues to create a significant need for preventive healthcare and evidence-based treatment strategies. At the same time, innovations in GLP-1-based therapies, artificial intelligence, wearable technologies, precision nutrition, and digital weight-management platforms are reshaping obesity and metabolic healthcare.

This evolving landscape creates significant opportunities for physicians, researchers, nutrition professionals, healthcare providers, pharmaceutical companies, medical technology companies, and policymakers to innovate, collaborate, and contribute to the future of obesity prevention, metabolic health, and personalized patient care.